fxs_header_sponsor_anchor

News

China’s Amabassador to US: China launched a nationwide campaign to crack down on online sales of Fentanyl

Chinese Ambassador to the US, Cui Tiankai, tweeted out last minutes, “China takes a zero-tolerance attitude towards illegal drugs, and is committed to the strict enforcement of anti-drug policies. As of May 1st, 2019, China has listed all Fentanyl-like substances as class scheduled drugs.”

“China has also launched a nationwide awareness and action campaign to crack down on online sales of Fentanyl-like substances, and urged shipping companies to enhance screening of packages.”

This comes as a welcome news amid escalating US-China trade tensions, especially after the US President Donald Trump said last Friday that he is “ordering” the U.S. postal service and express shipping companies to “SEARCH FOR & REFUSE all deliveries of fentanyl,” a deadly synthetic opioid.

The US officials have long blamed China for the influx of fentanyl and related drugs reaching US borders.

However, no impact is seen on the market sentiment so far, as fresh US-China geopolitical concerns over South China Sea take over and spark flight to safety in Asia.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.